Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WuXi PharmaTech, Combined with U.S. Firm, Sets Sights on Global Market

This article was originally published in PharmAsia News

Executive Summary

BEIJING - Fresh after acquiring U.S. biologics firm AppTec Laboratory Services, WuXi PharmaTech is pushing to rapidly broaden its scope of operations and widen its customer base worldwide, according to WuXi CEO Li Ge
Advertisement

Related Content

Following Massive Loss Last Year, Chinese CRO WuXi PharmaTech Posts Remarkable Rebound During First Quarter Of 2009
Following Massive Loss Last Year, Chinese CRO WuXi PharmaTech Posts Remarkable Rebound During First Quarter Of 2009
Hit By U.S. Economic Tremors, Collapse In Biologics Business, WuXi PharmaTech Posts Massive Loss For 2008, American Unit AppTec Deeply Devalued
Hit By U.S. Economic Tremors, Collapse In Biologics Business, WuXi PharmaTech Posts Massive Loss For 2008, American Unit AppTec Deeply Devalued
WuXi PharmaTech To Transfer Biologics Testing And Manufacturing From U.S. AppTec To New China Lab
Insider Analysis From BioForesight: Navigating the Life Sciences Silk Road Frontier
WuXi PharmaTech Inks New Pact To Synthesize Compounds For AstraZeneca
WuXi PharmaTech Set For Sales Synergy with U.S. Subsidiary AppTec
WuXi PharmaTech Launches Talent Flow with Acquired U.S. Firm AppTec
WuXi PharmaTech Launches Talent Flow with Acquired U.S. Firm AppTec
Advertisement
UsernamePublicRestriction

Register

SC068597

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel